Health professionals are notified that Janssen Pharmaceutica Inc., has announced it will stop marketing Propulsid in the United States as of July 14, 2000. The effective date of the voluntary action is intended to provide adequate time for patients and their health care providers to make alternative treatment decisions.
[April 13, 2000 - Letter - Janssen Pharmaceutica
Health professionals are notified of important changes in the Propulsid labeling to reflect new safety information, including recommendations for performing diagnostics tests prior to any Propulsid use.
[January 24, 2000 - Letter - Janssen Pharmaceutical Research Foundation]